The latest study showed that NTR1 was expressed in 91.8% of PCa tissues, and all PSMA-negative tissues showed positive NTR1 expression, suggesting the potential complementary role of NTR1-targeted imaging or therapy (16). The gene discussed is FOLH1; the disease is posterior cortical atrophy.